Post-Market Observation Study of Intra-renal Drug Delivery (PROVIDE)
Public ClinicalTrials.gov record NCT01064895. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a prospective, observational, multi-center study with consecutive enrollment. Up to 500 patients will be enrolled. All (consecutive) adult patients in whom one or more components of the Benephit Infusion System are planned to be used at participating sites are eligible for enrollment. The objective of this post-marketing surveillance study is to collect clinical usage patterns of the Benephit Infusion Systems. As a result, AngioDynamics will be able to (1) Better understand and quantify usage patterns including patient characteristics, adjunctive procedures, and infusion agents, (2) Collect user-interface information and overall customer satisfaction, and (3) Monitor post-marketing device performance and safety for ISO quality adherence.
Study identification
- NCT ID
- NCT01064895
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2010
- Primary completion
- Nov 30, 2011
- Completion
- Nov 30, 2011
- Last update posted
- Nov 7, 2016
2010 – 2011
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Baptist Cardiac & Vascular Institute | Miami | Florida | 33176 | — |
| HealthwoRx South Florida Research Solutions | Miramar | Florida | 33025 | — |
| Bingham Memorial Hospital | Blackfoot | Idaho | 83221 | — |
| Cardiology Associates of NW Indiana | Munster | Indiana | 46321 | — |
| Midwest Cardiovascular Research Foundation | Davenport | Iowa | 52803 | — |
| King's Daughters Medical Center | Ashland | Kentucky | 41101 | — |
| Graves Gilbert Clinic | Bowling Green | Kentucky | 42101 | — |
| Sahetya Medical Institute | Bowling Green | Kentucky | 42101 | — |
| Western Kentucky Heart and Lung | Bowling Green | Kentucky | 42101 | — |
| University of Maryland Medical Center | Baltimore | Maryland | 42101 | — |
| St. John Hospital & Medical Center | Detroit | Michigan | 48236 | — |
| St. Joseph Health Center | Saint Charles | Missouri | 63301 | — |
| Chambersburg Hospital | Chambersburg | Pennsylvania | 17201 | — |
| Utah Cardiology PC | Layton | Utah | 84041 | — |
| Virginia Commonwealth University Medical Center | Richmond | Virginia | 23298 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01064895, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 7, 2016 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01064895 live on ClinicalTrials.gov.